Completed from United Kingdom
Just finished the Pharmacoeconomics course and loved it. It helped me nail the basics I was missing for my MSc – especially the parts on QALY calculations and price‑volume analysis. I actually used the case‑study on vaccine pricing in my own project and got a solid grade. The course materials were spot‑on: the videos were short and the reading list was packed with current articles. It was a relaxed but thorough learning vibe, and I’m happy with the skills I now have.
The Pharmacoeconomics course at Stanmore School of Business delivered exactly what I needed to meet my professional development goals. The modules on cost‑effectiveness analysis and budget impact modelling gave me the practical tools to evaluate new drug proposals at my workplace. I was able to apply the incremental cost‑effectiveness ratio (ICER) calculations to a real‑world oncology case study, which impressed senior management. The lecture slides were clear, up‑to‑date with the latest WHO guidelines, and the supplemental Excel templates saved me hours of work. Overall, the learning experience was seamless and highly relevant, and I feel fully equipped to contribute to health‑policy decisions.
Wow! This Pharmacoeconomics program blew me away with its depth and energy. I wanted to understand how to translate clinical outcomes into economic terms, and the hands‑on workshops on Markov modeling gave me exactly that. I built a cost‑utility model for a diabetes drug using the provided R scripts and presented it at my company’s strategy meeting – they were amazed! The course notes were crisp, full of real‑world examples from Indian healthcare settings, making everything feel instantly applicable. The enthusiastic teaching style kept me motivated throughout, and I’m thrilled with the knowledge I’ve gained.
The Pharmacoeconomics course offered a detailed and methodical approach that aligned perfectly with my goal of supporting health‑technology assessments in South Africa. The curriculum covered everything from sensitivity analysis to discounting techniques, and each concept was reinforced with comprehensive case studies – for instance, the analysis of a malaria intervention program using the WHO-CHOICE framework. The provided datasets and step‑by‑step guides allowed me to replicate the analyses independently, which boosted my confidence in conducting economic evaluations. While the workload was intense, the high‑quality video lectures and well‑structured reading materials made the learning process manageable and highly relevant to my field.
